These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1715515)

  • 1. Signal transduction. Immunosuppressants at work.
    DeFranco AL
    Nature; 1991 Aug; 352(6338):754-5. PubMed ID: 1715515
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction.
    Bierer BE; Schreiber SL; Burakoff SJ
    Transplantation; 1990 Jun; 49(6):1168-70. PubMed ID: 1694317
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemistry and biology of the immunophilins and their immunosuppressive ligands.
    Schreiber SL
    Science; 1991 Jan; 251(4991):283-7. PubMed ID: 1702904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
    Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract]   [Full Text] [Related]  

  • 5. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.
    Siekierka JJ; Hung SH; Poe M; Lin CS; Sigal NH
    Nature; 1989 Oct; 341(6244):755-7. PubMed ID: 2477714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of immunosuppressive agents.
    Borel JF; Baumann G
    Bull Mem Acad R Med Belg; 1994; 149(1-2):97-101; discussion 101-3. PubMed ID: 7531051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression. Binding by design.
    Ringe D
    Nature; 1991 May; 351(6323):185-6. PubMed ID: 1710317
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of action of rapamycin (Sirolimus, Rapamune).
    Molnar-Kimber KL
    Transplant Proc; 1996 Apr; 28(2):964-9. PubMed ID: 8623482
    [No Abstract]   [Full Text] [Related]  

  • 10. Interspecies comparison of the immunosuppressive efficacy and safety of FK 506.
    Thomson AW
    Transplant Proc; 1990 Feb; 22(1):100-5. PubMed ID: 1689883
    [No Abstract]   [Full Text] [Related]  

  • 11. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple actions of tacrolimus and cyclosporin A as specific inhibitors of calcineurin].
    Tamura K
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1118-30. PubMed ID: 9655970
    [No Abstract]   [Full Text] [Related]  

  • 13. Categorizing receptor-signaling pathways with FK 506 and rapamycin.
    Hultsch T; Hohman RJ
    Transplant Proc; 1991 Dec; 23(6):2961-3. PubMed ID: 1721328
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressive drugs and calcineurin].
    Masugi T; Otsuka K
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1739-43. PubMed ID: 9788176
    [No Abstract]   [Full Text] [Related]  

  • 15. [FK506 and kifunensine, new immunomodulators of microbial origin].
    Izumi S; Okuhara M
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1800-12. PubMed ID: 7692469
    [No Abstract]   [Full Text] [Related]  

  • 16. [A second target of cyclosporin A and FK506].
    Matsuda S; Koyasu S
    Tanpakushitsu Kakusan Koso; 2000 Aug; 45(11):1823-31. PubMed ID: 10936966
    [No Abstract]   [Full Text] [Related]  

  • 17. Study of the immunosuppressive properties of cyclosporine analogues.
    Reem GH; el Rouby S; Shi Y
    Ann N Y Acad Sci; 1993 Jun; 685():336-8. PubMed ID: 8363236
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes.
    Fujii Y; Fujii S; Kaneko T
    Transplantation; 1989 Jun; 47(6):1081-3. PubMed ID: 2472025
    [No Abstract]   [Full Text] [Related]  

  • 19. Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats.
    Woo J; Ross CS; Milton JI; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1642-4. PubMed ID: 1697112
    [No Abstract]   [Full Text] [Related]  

  • 20. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.